Vertex Pharmaceuticals Incorporated Stock
Equities
VRTX
US92532F1003
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
483.3 USD | +0.05% |
|
+2.79% | +18.77% |
11:25am | RBC Adjusts Price Target on Vertex Pharmaceuticals to $421 From $424 | MT |
Jun. 07 | Vertex Pharmaceuticals Says Phase 3 Data Show Trikafta Improves Lung Function in Cystic Fibrosis Patients | MT |
Financials (USD)
Sales 2024 * | 10.75B | Sales 2025 * | 11.67B | Capitalization | 125B |
---|---|---|---|---|---|
Net income 2024 * | 3.96B | Net income 2025 * | 4.46B | EV / Sales 2024 * | 10.3 x |
Net cash position 2024 * | 13.97B | Net cash position 2025 * | 18.59B | EV / Sales 2025 * | 9.09 x |
P/E ratio 2024 * |
32.1
x | P/E ratio 2025 * |
28.4
x | Employees | 5,400 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.9% |
Latest transcript on Vertex Pharmaceuticals Incorporated
1 day | +0.05% | ||
1 week | +2.79% | ||
Current month | +6.14% | ||
1 month | +14.31% | ||
3 months | +16.85% | ||
6 months | +38.02% | ||
Current year | +18.77% |
![Extreme 474.16](/images/extremecours_fleche.png)
![Extreme 422.4401](/images/extremecours_fleche.png)
![Extreme 391.01](/images/extremecours_fleche.png)
![Extreme 331.87](/images/extremecours_fleche.png)
![Extreme 176.36](/images/extremecours_fleche.png)
![Extreme 165.23](/images/extremecours_fleche.png)
![Extreme 63.68](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 51 | 17-01-31 | |
Jeffrey Leiden
CHM | Chairman | 68 | 09-07-07 |
Charles Wagner
DFI | Director of Finance/CFO | 56 | 19-04-09 |
Members of the board | Title | Age | Since |
---|---|---|---|
Alan Garber
BRD | Director/Board Member | 68 | 17-06-07 |
Jeffrey Leiden
CHM | Chairman | 68 | 09-07-07 |
Bruce Sachs
BRD | Director/Board Member | 64 | 97-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
7.67% | 0 M€ | 0.00% | - | |
7.08% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-10 | 483.3 | +0.05% | 1,253,805 |
24-06-07 | 483 | -0.51% | 944,440 |
24-06-06 | 485.5 | +0.52% | 1,263,810 |
24-06-05 | 483 | +1.70% | 1,196,706 |
24-06-04 | 475 | +1.01% | 1,112,438 |
Delayed Quote Nasdaq, June 10, 2024 at 04:00 pm EDT
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.77% | 125B | |
+14.05% | 108B | |
-7.16% | 23.64B | |
+2.68% | 22.39B | |
-11.55% | 17.78B | |
-41.74% | 16.43B | |
-13.47% | 16.34B | |
+2.23% | 13.56B | |
+27.13% | 11.59B | |
+93.29% | 9.66B |
- Stock Market
- Equities
- VRTX Stock